Geleen
Netherlands
10
2020-11-05
10
2021-02-16
These are the the leading inventors for applications assigned to EnzyPep B.V.:
EnzyPep B.V. based in Geleen, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Chemo-enzymatic synthesis of semaglutide, liraglutide and GLP-1
#2 | 2020-08-20 ✅ Patent 10,858,414 granted on 2020-12-08Chemo-enzymatic synthesis of semaglutide, liraglutide and GLP-1
#3 | 2019-11-14 ✅ Patent 10,883,132 granted on 2021-01-05Chemo-enzymatic synthesis of Semaglutide, Liraglutide and GLP-1
#4 | 2019-03-14 ✅ Patent 10,336,994 granted on 2019-07-02Subtilisin variants having a mutation in the S2 or S2# pocket
#5 | 2019-01-31 ✅ Patent 10,253,061 granted on 2019-04-09Peptide fragment condensation and cyclisation using a subtilisin variant with improved synthesis over hydrolysis ratio
#6 | 2018-07-05 ✅ Patent 10,752,931 granted on 2020-08-25Designing an enzymatic peptide fragment condensation strategy
#7 | 2017-10-26 ✅ Patent 10,138,268 granted on 2018-11-27Peptide fragment condensation and cyclisation using a subtilisin variant with improved synthesis over hydrolysis ratio
#8 | 2015-02-05 ✅ Patent 9,598,714 granted on 2017-03-21Side-chain protected oligopeptide fragment condensation using subtilisins in organic solvents
#9 | 2012-05-24 ✅ Patent 8,883,444 granted on 2014-11-11Peptide synthesis using enzymatic activation and coupling
#10 | 2010-12-09 ✅ Patent 8,450,084 granted on 2013-05-28Chemo-enzymatic peptide synthesis via C-terminal ester interconversion
Also check out ENZYPEP B.V.'s (Geleen, Netherlands) applicant profile with 6 patent applications submitted.
87364 ⎘